Health maintenance issues of the elderly. Vision: age-related macular degeneration.

Research output: Contribution to journalArticle

Abstract

Age-related macular degeneration (AMD) is the leading cause of irreversible severe visual loss in the United States among persons over 50 years old. The majority of patients who develop severe visual loss from AMD have exudative disease. Treatment for AMD has been shown to be effective for only a small portion of patients who have well-defined choroidal neovascular membranes (CNVM) outside the foveal center. Even when successfully treated, severe visual loss is postponed for only about 18 months because of the high rate of recurrent CNVMs extending through the fovea. Presently, low-vision aids are the only treatment available for the majority of patients with exudative disease.

Original languageEnglish (US)
Pages (from-to)135-137
Number of pages3
JournalMaryland medical journal (Baltimore, Md. : 1985)
Volume38
Issue number2
StatePublished - Feb 1989
Externally publishedYes

Fingerprint

Macular Degeneration
Health
Low Vision
Membranes
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{4eb27c80d0f84682b31e5d4e0cba1f05,
title = "Health maintenance issues of the elderly. Vision: age-related macular degeneration.",
abstract = "Age-related macular degeneration (AMD) is the leading cause of irreversible severe visual loss in the United States among persons over 50 years old. The majority of patients who develop severe visual loss from AMD have exudative disease. Treatment for AMD has been shown to be effective for only a small portion of patients who have well-defined choroidal neovascular membranes (CNVM) outside the foveal center. Even when successfully treated, severe visual loss is postponed for only about 18 months because of the high rate of recurrent CNVMs extending through the fovea. Presently, low-vision aids are the only treatment available for the majority of patients with exudative disease.",
author = "Bressler, {Susan B}",
year = "1989",
month = "2",
language = "English (US)",
volume = "38",
pages = "135--137",
journal = "Maryland Medical Journal",
issn = "1538-2656",
publisher = "Medical and Chirugical Faculty of Maryland",
number = "2",

}

TY - JOUR

T1 - Health maintenance issues of the elderly. Vision

T2 - age-related macular degeneration.

AU - Bressler, Susan B

PY - 1989/2

Y1 - 1989/2

N2 - Age-related macular degeneration (AMD) is the leading cause of irreversible severe visual loss in the United States among persons over 50 years old. The majority of patients who develop severe visual loss from AMD have exudative disease. Treatment for AMD has been shown to be effective for only a small portion of patients who have well-defined choroidal neovascular membranes (CNVM) outside the foveal center. Even when successfully treated, severe visual loss is postponed for only about 18 months because of the high rate of recurrent CNVMs extending through the fovea. Presently, low-vision aids are the only treatment available for the majority of patients with exudative disease.

AB - Age-related macular degeneration (AMD) is the leading cause of irreversible severe visual loss in the United States among persons over 50 years old. The majority of patients who develop severe visual loss from AMD have exudative disease. Treatment for AMD has been shown to be effective for only a small portion of patients who have well-defined choroidal neovascular membranes (CNVM) outside the foveal center. Even when successfully treated, severe visual loss is postponed for only about 18 months because of the high rate of recurrent CNVMs extending through the fovea. Presently, low-vision aids are the only treatment available for the majority of patients with exudative disease.

UR - http://www.scopus.com/inward/record.url?scp=0024617781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024617781&partnerID=8YFLogxK

M3 - Article

C2 - 2915618

AN - SCOPUS:0024617781

VL - 38

SP - 135

EP - 137

JO - Maryland Medical Journal

JF - Maryland Medical Journal

SN - 1538-2656

IS - 2

ER -